SCHEMBL16410729

SCHEMBL16410729

CCCC1(CC)C(NNCc2cccc(Cl)c2)=Nc2c(NCN=[N+]=[N-])cccc2N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410709 0.72 CD38 (0.34) —
SCHEMBL16410732 0.68 NOS3 (0.31) —
SCHEMBL16410695 0.65 — —
SCHEMBL16410671 0.65 HDAC1 (0.33) —
SCHEMBL16410647 0.64 CYP1A2 (0.32) —
SCHEMBL16410611 0.62 — —
SCHEMBL16410838 0.61 CYP3A4 (0.32) —
SCHEMBL16410683 0.60 PIK3CA (0.32) —
SCHEMBL16410561 0.59 TSHR (0.39) —
SCHEMBL16410774 0.58 MEN1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback